Zobrazeno 1 - 10
of 100
pro vyhledávání: '"diabetic cardiomyopathy (DCM)"'
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 5, p 165 (2024)
Diabetic cardiomyopathy is an insidious and fatal disease, imposing major financial and social burdens on affected individuals. Among the various methods proposed for the treatment of diabetic cardiomyopathy (DCM), treatments with natural products ha
Externí odkaz:
https://doaj.org/article/6cd518dd32fa4642936512c8a186207b
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Diabetes mellitus (DM) is a group of metabolic diseases caused by absolute or relative deficiency of insulin secretion and characterized by chronic hyperglycemia. Its complications affect almost every tissue of the body, usually leading to blindness,
Externí odkaz:
https://doaj.org/article/f0d9f9c633fb437d94c7d63b98a57b76
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Diabetic cardiomyopathy (DCM) is the primary cause of morbidity and mortality in diabetic cardiovascular complications, which initially manifests as cardiac hypertrophy, myocardial fibrosis, dysfunctional remodeling, and diastolic dysfunction, follow
Externí odkaz:
https://doaj.org/article/4ab2d4353fec471180dee1780770ab1d
Autor:
Mingyu Hao, Jianxin Deng, Xiaohong Huang, Haiyan Li, Huiting Ou, Xiangsheng Cai, Jiajie She, Xueting Liu, Ling Chen, Shujuan Chen, Wenlan Liu, Dewen Yan
Publikováno v:
Frontiers in Physiology, Vol 13 (2022)
Diabetic cardiomyopathy (DCM) is one of the most essential cardiovascular complications in diabetic patients associated with glucose and lipid metabolism disorder, fibrosis, oxidative stress, and inflammation in cardiomyocytes. Despite increasing res
Externí odkaz:
https://doaj.org/article/5225faf4d8914f60a11d6912960c8051
Autor:
George J. Dugbartey, Quinsker L. Wonje, Karl K. Alornyo, Louis Robertson, Ismaila Adams, Vincent Boima, Samuel D. Mensah
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Diabetic cardiomyopathy (DCM) is a major long-term complication of diabetes mellitus, accounting for over 20% of annual mortality rate of diabetic patients globally. Although several existing anti-diabetic drugs have improved glycemic sta
Externí odkaz:
https://doaj.org/article/a1362a4d62b347e6ba42917ab1724264
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Heart failure is an important manifestation of diabetic heart disease. Before the development of symptomatic heart failure, as much as 50% of patients with type 2 diabetes mellitus (T2DM) develop asymptomatic left ventricular dysfunction including le
Externí odkaz:
https://doaj.org/article/a27c22d4aad24ce7a5117ad9e2a5fd11
Autor:
M. Annandale, L. J. Daniels, X. Li, J. P. H. Neale, A. H. L. Chau, H. A. Ambalawanar, S. L. James, P. Koutsifeli, L. M. D. Delbridge, K. M. Mellor
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Cardiovascular disease is one of the leading causes of mortality in diabetes. High fructose consumption has been linked with the development of diabetes and cardiovascular disease. Serum and cardiac tissue fructose levels are elevated in diabetic pat
Externí odkaz:
https://doaj.org/article/c8fb87c9285043f69b7a30f0929fe391
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Heart failure is a serious comorbidity and the most common cause of mortality in diabetes patients. Diabetic cardiomyopathy (DCM) features impaired cellular structure and function, culminating in heart failure; however, there is a dearth of specific
Externí odkaz:
https://doaj.org/article/dd606e8465804e2cb55d41fc14282819